Postoperative Neutrophil-to-Lymphocyte Ratio Change Predicts Survival of Patients with Small Hepatocellular Carcinoma Undergoing Radiofrequency Ablation

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Dan, Jiaqiang ^a   Zhang, Yaojun ^a   Peng, Zhenwei ^a,b   Huang, Junting ^a   Gao, Hengjun ^a   Xu, Li ^a   Chen, Minshan ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADULT; AGE DISTRIBUTION; AGED; CANCER PROGNOSIS; CANCER SURVIVAL; CELLULAR PARAMETERS; CLINICAL ASSESSMENT; CLINICAL FEATURE; COHORT ANALYSIS; FEMALE; FEVER; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL TO LYMPHOCYTE RATIO; OVERALL SURVIVAL; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RADIOFREQUENCY ABLATION; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; REVIEW; SEX DIFFERENCE; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; FEMALE; HUMANS; LEUKOCYTE COUNT; LIVER NEOPLASMS; LYMPHOCYTES; MALE; MIDDLE AGED; NEUTROPHILS; POSTOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84875028758     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058184     Document Type: Review

References (41)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917.
2. Lencioni R, Cioni D, Crocetti L, Franchini C, Pina CD, et al. (2005) Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234: 961-967.
3. Tateishi R, Shiina S, Teratani T, Obi S, Sato S, et al. (2005) Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 103: 1201-1209.
4. Mulier S, Mulier P, Ni Y, Miao Y, Dupas B, et al. (2002) Complications of radiofrequency coagulation of liver tumours. Br J Surg 89: 1206-1222.
5. Lau WY, Leung TW, Yu SC, Ho SK, (2003) Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future. Ann Surg 237: 171-179.
6. Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, et al. (2006) A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 243: 321-328.
7. Lupo L, Panzera P, Giannelli G, Memeo M, Gentile A, et al. (2007) Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection? HPB (Oxford) 9: 429-434.
8. Guglielmi A, Ruzzenente A, Valdegamberi A, Pachera S, Campagnaro T, et al. (2008) Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis. J Gastrointest Surg 12: 192-198.
9. Hong SN, Lee SY, Choi MS, Lee JH, Koh KC, et al. (2005) Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function. J Clin Gastroenterol 39: 247-252.
10. Peng ZW, Zhang YJ, Chen MS, Liang HH, Li JQ, et al. (2008) Risk factors of survival after percutaneous radiofrequency ablation of hepatocellular carcinoma. Surg Oncol 17: 23-31.
11. Lam VW, Ng KK, Chok KS, Cheung TT, Yuen J, et al. (2008) Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma. J Am Coll Surg 207: 20-29.
12. Ng KK, Poon RT, Lo CM, Yuen J, Tso WK, et al. (2008) Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma. J Gastrointest Surg 12: 183-191.
13. Shiozawa K, Watanabe M, Wakui N, Ikehara T, Iida K, et al. (2009) Risk factors for the local recurrence of hepatocellular carcinoma after single-session percutaneous radiofrequency ablation with a single electrode insertion. Mol Med Report 2: 89-95.
14. Lin SM, (2010) Local ablation for hepatocellular carcinoma in Taiwan: different points between Japan, Asia and West. Oncology 78Suppl 1: 102-106.
15. Takahashi S, Kudo M, Chung H, Inoue T, Ishikawa E, et al. (2007) Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy. Oncology 72Suppl 1: 98-103.
16. Zahorec R, (2001) Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 102: 5-14.
17. Chua W, Clarke SJ, Charles KA (2011) Systemic inflammation and prediction of chemotherapy outcomes in patients receiving docetaxel for advanced cancer. Support Care Cancer.
18. Jung MR, Park YK, Jeong O, Seon JW, Ryu SY, et al. (2011) Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer. J Surg Oncol 104: 504-510.
19. He JR, Shen GP, Ren ZF, Qin H, Cui C, et al. (2012) Pretreatment levels of peripheral neutrophils and lymphocytes as independent prognostic factors in patients with nasopharyngeal carcinoma. Head Neck.
20. Thavaramara T, Phaloprakarn C, Tangjitgamol S, Manusirivithaya S, (2011) Role of neutrophil to lymphocyte ratio as a prognostic indicator for epithelial ovarian cancer. J Med Assoc Thai 94: 871-877.
21. Huang ZL, Luo J, Chen MS, Li JQ, Shi M, (2011) Blood neutrophil-to-lymphocyte ratio predicts survival in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization. J Vasc Interv Radiol 22: 702-709.
22. Gomez D, Farid S, Malik HZ, Young AL, Toogood GJ, et al. (2008) Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. World J Surg 32: 1757-1762.
23. Halazun KJ, Hardy MA, Rana AA, Woodland DT, Luyten EJ, et al. (2009) Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma. Ann Surg 250: 141-151.
24. Wang GY, Yang Y, Li H, Zhang J, Jiang N, et al. (2011) A scoring model based on neutrophil to lymphocyte ratio predicts recurrence of HBV-associated hepatocellular carcinoma after liver transplantation. PLoS One 6: e25295.
25. Halazun KJ, Aldoori A, Malik HZ, Al-Mukhtar A, Prasad KR, et al. (2008) Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol 34: 55-60.
26. Kishi Y, Kopetz S, Chun YS, Palavecino M, Abdalla EK, et al. (2009) Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy. Ann Surg Oncol 16: 614-622.
27. Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y, et al. (2007) The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology 73: 215-220.
28. Zhang Y, Peng Z, Chen M, Liu F, Huang J, et al. (2012) Elevated neutrophil to lymphocyte ratio might predict poor prognosis for colorectal liver metastasis after percutaneous radiofrequency ablation. Int J Hyperthermia 28: 132-140.
29. Gomez D, Farid S, Malik HZ, Young AL, Toogood GJ, et al. (2008) Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. World J Surg 32: 1757-1762.
30. Hung HY, Chen JS, Yeh CY, Changchien CR, Tang R, et al. (2011) Effect of preoperative neutrophil-lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy. Int J Colorectal Dis 26: 1059-1065.
31. Kusumanto YH, Dam WA, Hospers GA, Meijer C, Mulder NH, (2003) Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis 6: 283-287.
32. Fondevila C, Metges JP, Fuster J, Grau JJ, Palacin A, et al. (2004) p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer. Br J Cancer 90: 206-215.
33. Ding PR, An X, Zhang RX, Fang YJ, Li LR, et al. (2010) Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer. Int J Colorectal Dis 25: 1427-1433.
34. Ohno Y, Nakashima J, Ohori M, Gondo T, Hatano T, et al. (2012) Followup of Neutrophil-to-Lymphocyte Ratio and Recurrence of Clear Cell Renal Cell Carcinoma. J Urol 187: 411-417.
35. Chen TM, Lin CC, Huang PT, Wen CF, (2012) Neutrophil-to-lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation. J Gastroenterol Hepatol 27: 553-561.
36. Sanchez-Ortiz RF, Tannir N, Ahrar K, Wood CG, (2003) Spontaneous regression of pulmonary metastases from renal cell carcinoma after radio frequency ablation of primary tumor: an in situ tumor vaccine? J Urol 170: 178-179.
37. Rao P, Escudier B, de Baere T, (2011) Spontaneous regression of multiple pulmonary metastases after radiofrequency ablation of a single metastasis. Cardiovasc Intervent Radiol 34: 424-430.
38. Fagnoni FF, Zerbini A, Pelosi G, Missale G, (2008) Combination of radiofrequency ablation and immunotherapy. Front Biosci 13: 369-381.
39. den Brok MH, Sutmuller RP, van der Voort R, Bennink EJ, Figdor CG, et al. (2004) In situ tumor ablation creates an antigen source for the generation of antitumor immunity. Cancer Res 64: 4024-4029.
40. Bruix J, Sherman M, (2005) Management of hepatocellular carcinoma. Hepatology 42: 1208-1236.
41. Zhang YJ, Liang HH, Chen MS, Guo RP, Li JQ, et al. (2007) Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial. Radiology 244: 599-607.